Skip to main content

Technological Advancements play Crucial Role in Future of Big Data in Healthcare Market

big data in healthcare market

 

The global healthcare industry is expected to significantly benefit from the growth in the adoption of big data technologies. The advantages of the technology are immense and proven. Future growth is expected to be driven by more countries and their healthcare systems going digital and focusing on data-driven healthcare. The healthcare industry is expected to be significantly boosted by the growing demand for evidence-based clinical care in developing countries. Technological advancements anticipated from 2022 to 2031 are expected to play a crucial role in deciding the future of big data in healthcare market and the level of adoption. Currently, the market growth is hampered by a large volume of unstructured data, slow pace of adoption of digital health in some emerging countries, and lack of sufficient rules and regulations to support mass adoption in emerging countries.

The global big data in healthcare market was valued at $32,925.1 million in 2021 and is anticipated to grow to $130,132.1 million by the end of 2031 at a projected CAGR of 13.96% during the forecast period 2022-2031. The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no overall impact on the market due to any potential COVID-19 waves in the future.

BIS Research big data in healthcare market


Impact of COVID- 19 on the Global Big Data in Healthcare Market

Immediately after the outbreak of COVID-19, the focus of healthcare systems across the globe switched to managing the crisis caused by the pandemic. This led to hospital budgets shrinking. Elective treatments were delayed, refocusing efforts toward the treatment of COVID-19 patients. During the initial phase of the pandemic, several fields in healthcare faced losses due to a decline in visitations. Big data has been at the center of innovation related to COVID-19 treatments in 2020 and 2021. Established players, emerging startups, hospitals, and research facilities have made use of big data to solve the challenges posed by the COVID-19 pandemic. The demand for real-world evidence grew significantly during the COVID-19 pandemic phase.

 Addressable Market Size and Forecast based on Region

 The North America region has one of the most technologically advanced healthcare systems globally. The U.S. government has launched incentive-based programs to encourage providers and payers to implement information technology in their health systems. These initiatives are shifting the market toward a value-based care model as opposed to fee-for-service model.

Europe is one of the early adopters of systems based on technologies such as artificial intelligence and machine learning. These technologies have great potential to aid healthcare professionals in providing improved patient-specific care.

The Asia-Pacific region consists of many emerging economies that are undergoing significant technological advancements along with improvements in their healthcare systems. In many emerging countries in the Asia-Pacific region, the healthcare sector is getting more attention than in the past. Countries such as India and China have several digital health initiatives which have witnessed accelerated implementation during the COVID-19 pandemic.

Big Data in Healthcare Market


Key Competitors in the Global Big Data in Healthcare Market

 The major companies operating in the big data in healthcare market are McKesson, Epic Systems Corporation, and Cerner Corporation. In terms of technological development, most of the players in the market are focused on increasing the volume of structured data and enhancing the interoperability of the available data.

Different Regions Expected to Perform in terms of Market Growth

 Currently, the North America and Europe markets are leading in terms of value. According to primary discussions conducted by BIS Research, currently, efforts are focused on making more of the healthcare data interoperable and fit for data analytics and insights extraction. The Asia-Pacific big data in healthcare market has substantial scope for growth during the forecast period 2022-2031. Growth in support for digital health from local governments is expected to be the first big and crucial step toward increasing the adoption of big data in healthcare in emerging countries during 2022-2031.

RELATED MARKET REPORTS

Global AI in Healthcare Market

Global Clinical Decision Support Systems (CDSS) Market


ABOUT BIS HEALTHCARE

 BIS healthcare vertical offers intelligence in the healthcare technology market for precision medicine, robotics and imaging, life sciences and biopharma, medical devices, digital health, and other emerging healthcare technologies, covering the entire industry spectrum. In the past eight years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating ‘Top 25 Voices’ in precision medicine on its InsightMonk platform for the past two years successfully.



Comments

Popular posts from this blog

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applicatio

Growing Focus on Patient-Centered Healthcare led to Rise in Urgent Care Apps Market

Urgent care apps are intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring.   Treatment can be offered remotely via text/audio/video calls, or help can be arranged to usher the patient to the nearest hospital. The widespread adoption of smartphones and increased demand for urgent and convenient access to care will be crucial to the market’s growth.  The global urgent care apps market was valued at $973.6 million in 2020 and is anticipated to grow to $10,150.5 million by the end of 2030 at a projected CAGR of 26.32% during the forecast period 2021-2030.   The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no visible impact of COVID-19 beyond 2030. The changes in the market during that timeline can build upon the developments of

Neoantigen Cancer Vaccine Market Technology Developments and Future Growth

  Looking at the recent oncology care trends, the World Heart Foundation estimates the global cancer treatment expenditure to reach $XX billion in the year 2031.   The increase in overall burden provides an opportunity for several companies to step in and introduce their innovative products in the market. The emergence of the neoantigen cancer vaccine can be considered as an evident example of emerging oncology care that can possibly prevail over the existing hurdles of treatment un-specificity and safety benchmarks. The global neoantigen cancer vaccine industry analysis by BIS Research projects the market to grow at a significant CAGR of 77.73% during the forecast period 2024-2031. The  neoantigen cancer vaccine market  is expected to generate $35.5 million in revenue in 2024, owing to the expected launch of the first neoantigen vaccine, DC vaccine in the market. The neoantigen cancer vaccine market growth has been primarily attributed to major drivers in this market, such as rising p